サンプル依頼リスト カート
  • English
  • Korean
市場調査レポート
商品コード
1534560

ヒトインスリンの世界市場規模、シェア、動向分析：症状別、製品タイプ別、インスリンタイプ別、流通チャネル別、地域別展望と予測（2024年～2031年）

Global Human Insulin Market Size, Share & Trends Analysis Report By Indication, By Product Type (Pens, Syringes, and Others), By Type of Insulin, By Distribution Channel, By Regional Outlook and Forecast, 2024 - 2031
出版日: | 発行: KBV Research | ページ情報: 英文 268 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.72円
ヒトインスリンの世界市場規模、シェア、動向分析：症状別、製品タイプ別、インスリンタイプ別、流通チャネル別、地域別展望と予測（2024年～2031年）
出版日: 2024年08月09日
発行: KBV Research
ページ情報: 英文 268 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のヒトインスリンの市場規模は、予測期間中に3.2%のCAGRで市場成長し、2031年までに205億米ドルに達すると予想されています。

さらに、インスリンペン、ポンプ、持続血糖モニタリング（CGM）システムなどのイノベーションは糖尿病管理に革命をもたらし、患者のコンプライアンス、利便性、全体的な生活の質を向上させました。持続血糖モニタリングシステムは、糖尿病管理技術の飛躍的な進歩を表しています。したがって、これらの技術の継続的な進化は、市場の成長の大きな原動力となっています。

しかし、過去数十年間にインスリンの価格は劇的に上昇し、インフレや賃金上昇をはるかに上回っています。先進国でも、インスリンの高コストは大きな課題となっています。健康保険でコストの一部をカバーできるとしても、自己負担額は依然として法外に高額です。そのため、インスリンの高コストは市場の成長を妨げています。

さらに、パンデミックの経済的影響が市場に負担をかけました。多くの人が失業や収入の減少により経済的困難に直面し、インスリンを含む医薬品を購入する余裕がなくなりました。ソーシャルディスタンス措置と対面診療の制限により、遠隔地での糖尿病管理には遠隔医療が不可欠になりました。したがって、パンデミックは市場に全体的に悪影響を及ぼしました。

症状の展望

症状別では、市場は1型糖尿病、2型糖尿病、妊娠糖尿病に分類されます。2型糖尿病セグメントは、2023年に市場で40％の収益シェアを記録しました。2型糖尿病の有病率は1型糖尿病よりも高く、一般的に太りすぎ、身体活動不足、不健康な食生活などのライフスタイルの変数に関連しています。

製品タイプの展望

製品タイプ別では、市場はペン、注射器、その他に分かれています。注射器セグメントは、2023年に市場で30％の収益シェアを獲得しました。購入しやすい価格は重要な推進力であり、注射器は低所得国と中所得国の患者や広範な健康保険に加入していない人々にとって実行可能な選択肢となっています。

目次

第1章 市場範囲と調査手法

  • 市場の定義
  • 目的
  • 市場範囲
  • セグメンテーション
  • 調査手法

第2章 市場要覧

  • 主なハイライト

第3章 市場概要

  • イントロダクション
    • 概要
      • 市場構成とシナリオ
  • 市場に影響を与える主な要因
    • 市場促進要因
    • 市場抑制要因
    • 市場機会
    • 市場の課題
  • ポーターのファイブフォース分析

第4章 世界のヒトインスリン市場：症状別

  • 世界の1型糖尿病市場：地域別
  • 世界の2型糖尿病市場：地域別
  • 世界の妊娠糖尿病市場：地域別

第5章 世界のヒトインスリン市場：製品タイプ別

  • 世界のペン市場：地域別
  • 世界の注射器市場：地域別
  • 世界のその他の市場：地域別

第6章 世界のヒトインスリン市場：インスリンタイプ別

  • 世界の超速効型インスリン市場：地域別
  • 世界の速効型インスリン市場：地域別
  • 世界の中間型インスリン市場：地域別
  • 世界のその他の市場：地域別

第7章 世界のヒトインスリン市場：流通チャネル別

  • 世界の院内薬局市場：地域別
  • 世界のドラッグストアと小売薬局市場：地域別
  • 世界のオンラインプロバイダー市場：地域別

第8章 世界のヒトインスリン市場：地域別

  • 北米
    • 北米のヒトインスリン市場：国別
      • 米国
      • カナダ
      • メキシコ
      • その他北米
  • 欧州
    • 欧州のヒトインスリン市場：国別
      • ドイツ
      • 英国
      • フランス
      • ロシア
      • スペイン
      • イタリア
      • その他欧州
  • アジア太平洋
    • アジア太平洋のヒトインスリン市場：国別
      • 中国
      • 日本
      • インド
      • 韓国
      • シンガポール
      • マレーシア
      • その他アジア太平洋
  • ラテンアメリカ・中東・アフリカ
    • ラテンアメリカ・中東・アフリカのヒトインスリン市場：国別
      • ブラジル
      • アルゼンチン
      • アラブ首長国連邦
      • サウジアラビア
      • 南アフリカ
      • ナイジェリア
      • その他ラテンアメリカ・中東・アフリカ

第9章 企業プロファイル

  • Biocon Limited
  • Tonghua Dongbao Pharmaceutical Co, Ltd.
  • Lupin Limited
  • MannKind Corporation
  • Sanofi SA
  • Novo Nordisk A/S
  • Medtronic PLC
  • Eli Lilly And Company
  • Pfizer, Inc

第10章 ヒトインスリン市場における成功必須条件

図表

LIST OF TABLES

  • TABLE 1 Global Human Insulin Market, 2020 - 2023, USD Million
  • TABLE 2 Global Human Insulin Market, 2024 - 2031, USD Million
  • TABLE 3 Global Human Insulin Market by Indication, 2020 - 2023, USD Million
  • TABLE 4 Global Human Insulin Market by Indication, 2024 - 2031, USD Million
  • TABLE 5 Global Type 1 Diabetes Market by Region, 2020 - 2023, USD Million
  • TABLE 6 Global Type 1 Diabetes Market by Region, 2024 - 2031, USD Million
  • TABLE 7 Global Type 2 Diabetes Market by Region, 2020 - 2023, USD Million
  • TABLE 8 Global Type 2 Diabetes Market by Region, 2024 - 2031, USD Million
  • TABLE 9 Global Gestational Diabetes Market by Region, 2020 - 2023, USD Million
  • TABLE 10 Global Gestational Diabetes Market by Region, 2024 - 2031, USD Million
  • TABLE 11 Global Human Insulin Market by Product Type, 2020 - 2023, USD Million
  • TABLE 12 Global Human Insulin Market by Product Type, 2024 - 2031, USD Million
  • TABLE 13 Global Pens Market by Region, 2020 - 2023, USD Million
  • TABLE 14 Global Pens Market by Region, 2024 - 2031, USD Million
  • TABLE 15 Global Syringes Market by Region, 2020 - 2023, USD Million
  • TABLE 16 Global Syringes Market by Region, 2024 - 2031, USD Million
  • TABLE 17 Global Others Market by Region, 2020 - 2023, USD Million
  • TABLE 18 Global Others Market by Region, 2024 - 2031, USD Million
  • TABLE 19 Global Human Insulin Market by Type of Insulin, 2020 - 2023, USD Million
  • TABLE 20 Global Human Insulin Market by Type of Insulin, 2024 - 2031, USD Million
  • TABLE 21 Global Rapid-acting insulin Market by Region, 2020 - 2023, USD Million
  • TABLE 22 Global Rapid-acting insulin Market by Region, 2024 - 2031, USD Million
  • TABLE 23 Global Short-acting insulin Market by Region, 2020 - 2023, USD Million
  • TABLE 24 Global Short-acting insulin Market by Region, 2024 - 2031, USD Million
  • TABLE 25 Global Intermediate-acting insulin Market by Region, 2020 - 2023, USD Million
  • TABLE 26 Global Intermediate-acting insulin Market by Region, 2024 - 2031, USD Million
  • TABLE 27 Global Others Market by Region, 2020 - 2023, USD Million
  • TABLE 28 Global Others Market by Region, 2024 - 2031, USD Million
  • TABLE 29 Global Human Insulin Market by Distribution Channel, 2020 - 2023, USD Million
  • TABLE 30 Global Human Insulin Market by Distribution Channel, 2024 - 2031, USD Million
  • TABLE 31 Global Hospital Pharmacies Market by Region, 2020 - 2023, USD Million
  • TABLE 32 Global Hospital Pharmacies Market by Region, 2024 - 2031, USD Million
  • TABLE 33 Global Drug Stores & Retail Pharmacies Market by Region, 2020 - 2023, USD Million
  • TABLE 34 Global Drug Stores & Retail Pharmacies Market by Region, 2024 - 2031, USD Million
  • TABLE 35 Global Online Providers Market by Region, 2020 - 2023, USD Million
  • TABLE 36 Global Online Providers Market by Region, 2024 - 2031, USD Million
  • TABLE 37 Global Human Insulin Market by Region, 2020 - 2023, USD Million
  • TABLE 38 Global Human Insulin Market by Region, 2024 - 2031, USD Million
  • TABLE 39 North America Human Insulin Market, 2020 - 2023, USD Million
  • TABLE 40 North America Human Insulin Market, 2024 - 2031, USD Million
  • TABLE 41 North America Human Insulin Market by Indication, 2020 - 2023, USD Million
  • TABLE 42 North America Human Insulin Market by Indication, 2024 - 2031, USD Million
  • TABLE 43 North America Type 1 Diabetes Market by Country, 2020 - 2023, USD Million
  • TABLE 44 North America Type 1 Diabetes Market by Country, 2024 - 2031, USD Million
  • TABLE 45 North America Type 2 Diabetes Market by Country, 2020 - 2023, USD Million
  • TABLE 46 North America Type 2 Diabetes Market by Country, 2024 - 2031, USD Million
  • TABLE 47 North America Gestational Diabetes Market by Country, 2020 - 2023, USD Million
  • TABLE 48 North America Gestational Diabetes Market by Country, 2024 - 2031, USD Million
  • TABLE 49 North America Human Insulin Market by Product Type, 2020 - 2023, USD Million
  • TABLE 50 North America Human Insulin Market by Product Type, 2024 - 2031, USD Million
  • TABLE 51 North America Pens Market by Country, 2020 - 2023, USD Million
  • TABLE 52 North America Pens Market by Country, 2024 - 2031, USD Million
  • TABLE 53 North America Syringes Market by Country, 2020 - 2023, USD Million
  • TABLE 54 North America Syringes Market by Country, 2024 - 2031, USD Million
  • TABLE 55 North America Others Market by Country, 2020 - 2023, USD Million
  • TABLE 56 North America Others Market by Country, 2024 - 2031, USD Million
  • TABLE 57 North America Human Insulin Market by Type of Insulin, 2020 - 2023, USD Million
  • TABLE 58 North America Human Insulin Market by Type of Insulin, 2024 - 2031, USD Million
  • TABLE 59 North America Rapid-acting insulin Market by Country, 2020 - 2023, USD Million
  • TABLE 60 North America Rapid-acting insulin Market by Country, 2024 - 2031, USD Million
  • TABLE 61 North America Short-acting insulin Market by Country, 2020 - 2023, USD Million
  • TABLE 62 North America Short-acting insulin Market by Country, 2024 - 2031, USD Million
  • TABLE 63 North America Intermediate-acting insulin Market by Country, 2020 - 2023, USD Million
  • TABLE 64 North America Intermediate-acting insulin Market by Country, 2024 - 2031, USD Million
  • TABLE 65 North America Others Market by Country, 2020 - 2023, USD Million
  • TABLE 66 North America Others Market by Country, 2024 - 2031, USD Million
  • TABLE 67 North America Human Insulin Market by Distribution Channel, 2020 - 2023, USD Million
  • TABLE 68 North America Human Insulin Market by Distribution Channel, 2024 - 2031, USD Million
  • TABLE 69 North America Hospital Pharmacies Market by Country, 2020 - 2023, USD Million
  • TABLE 70 North America Hospital Pharmacies Market by Country, 2024 - 2031, USD Million
  • TABLE 71 North America Drug Stores & Retail Pharmacies Market by Country, 2020 - 2023, USD Million
  • TABLE 72 North America Drug Stores & Retail Pharmacies Market by Country, 2024 - 2031, USD Million
  • TABLE 73 North America Online Providers Market by Country, 2020 - 2023, USD Million
  • TABLE 74 North America Online Providers Market by Country, 2024 - 2031, USD Million
  • TABLE 75 North America Human Insulin Market by Country, 2020 - 2023, USD Million
  • TABLE 76 North America Human Insulin Market by Country, 2024 - 2031, USD Million
  • TABLE 77 US Human Insulin Market, 2020 - 2023, USD Million
  • TABLE 78 US Human Insulin Market, 2024 - 2031, USD Million
  • TABLE 79 US Human Insulin Market by Indication, 2020 - 2023, USD Million
  • TABLE 80 US Human Insulin Market by Indication, 2024 - 2031, USD Million
  • TABLE 81 US Human Insulin Market by Product Type, 2020 - 2023, USD Million
  • TABLE 82 US Human Insulin Market by Product Type, 2024 - 2031, USD Million
  • TABLE 83 US Human Insulin Market by Type of Insulin, 2020 - 2023, USD Million
  • TABLE 84 US Human Insulin Market by Type of Insulin, 2024 - 2031, USD Million
  • TABLE 85 US Human Insulin Market by Distribution Channel, 2020 - 2023, USD Million
  • TABLE 86 US Human Insulin Market by Distribution Channel, 2024 - 2031, USD Million
  • TABLE 87 Canada Human Insulin Market, 2020 - 2023, USD Million
  • TABLE 88 Canada Human Insulin Market, 2024 - 2031, USD Million
  • TABLE 89 Canada Human Insulin Market by Indication, 2020 - 2023, USD Million
  • TABLE 90 Canada Human Insulin Market by Indication, 2024 - 2031, USD Million
  • TABLE 91 Canada Human Insulin Market by Product Type, 2020 - 2023, USD Million
  • TABLE 92 Canada Human Insulin Market by Product Type, 2024 - 2031, USD Million
  • TABLE 93 Canada Human Insulin Market by Type of Insulin, 2020 - 2023, USD Million
  • TABLE 94 Canada Human Insulin Market by Type of Insulin, 2024 - 2031, USD Million
  • TABLE 95 Canada Human Insulin Market by Distribution Channel, 2020 - 2023, USD Million
  • TABLE 96 Canada Human Insulin Market by Distribution Channel, 2024 - 2031, USD Million
  • TABLE 97 Mexico Human Insulin Market, 2020 - 2023, USD Million
  • TABLE 98 Mexico Human Insulin Market, 2024 - 2031, USD Million
  • TABLE 99 Mexico Human Insulin Market by Indication, 2020 - 2023, USD Million
  • TABLE 100 Mexico Human Insulin Market by Indication, 2024 - 2031, USD Million
  • TABLE 101 Mexico Human Insulin Market by Product Type, 2020 - 2023, USD Million
  • TABLE 102 Mexico Human Insulin Market by Product Type, 2024 - 2031, USD Million
  • TABLE 103 Mexico Human Insulin Market by Type of Insulin, 2020 - 2023, USD Million
  • TABLE 104 Mexico Human Insulin Market by Type of Insulin, 2024 - 2031, USD Million
  • TABLE 105 Mexico Human Insulin Market by Distribution Channel, 2020 - 2023, USD Million
  • TABLE 106 Mexico Human Insulin Market by Distribution Channel, 2024 - 2031, USD Million
  • TABLE 107 Rest of North America Human Insulin Market, 2020 - 2023, USD Million
  • TABLE 108 Rest of North America Human Insulin Market, 2024 - 2031, USD Million
  • TABLE 109 Rest of North America Human Insulin Market by Indication, 2020 - 2023, USD Million
  • TABLE 110 Rest of North America Human Insulin Market by Indication, 2024 - 2031, USD Million
  • TABLE 111 Rest of North America Human Insulin Market by Product Type, 2020 - 2023, USD Million
  • TABLE 112 Rest of North America Human Insulin Market by Product Type, 2024 - 2031, USD Million
  • TABLE 113 Rest of North America Human Insulin Market by Type of Insulin, 2020 - 2023, USD Million
  • TABLE 114 Rest of North America Human Insulin Market by Type of Insulin, 2024 - 2031, USD Million
  • TABLE 115 Rest of North America Human Insulin Market by Distribution Channel, 2020 - 2023, USD Million
  • TABLE 116 Rest of North America Human Insulin Market by Distribution Channel, 2024 - 2031, USD Million
  • TABLE 117 Europe Human Insulin Market, 2020 - 2023, USD Million
  • TABLE 118 Europe Human Insulin Market, 2024 - 2031, USD Million
  • TABLE 119 Europe Human Insulin Market by Indication, 2020 - 2023, USD Million
  • TABLE 120 Europe Human Insulin Market by Indication, 2024 - 2031, USD Million
  • TABLE 121 Europe Type 1 Diabetes Market by Country, 2020 - 2023, USD Million
  • TABLE 122 Europe Type 1 Diabetes Market by Country, 2024 - 2031, USD Million
  • TABLE 123 Europe Type 2 Diabetes Market by Country, 2020 - 2023, USD Million
  • TABLE 124 Europe Type 2 Diabetes Market by Country, 2024 - 2031, USD Million
  • TABLE 125 Europe Gestational Diabetes Market by Country, 2020 - 2023, USD Million
  • TABLE 126 Europe Gestational Diabetes Market by Country, 2024 - 2031, USD Million
  • TABLE 127 Europe Human Insulin Market by Product Type, 2020 - 2023, USD Million
  • TABLE 128 Europe Human Insulin Market by Product Type, 2024 - 2031, USD Million
  • TABLE 129 Europe Pens Market by Country, 2020 - 2023, USD Million
  • TABLE 130 Europe Pens Market by Country, 2024 - 2031, USD Million
  • TABLE 131 Europe Syringes Market by Country, 2020 - 2023, USD Million
  • TABLE 132 Europe Syringes Market by Country, 2024 - 2031, USD Million
  • TABLE 133 Europe Others Market by Country, 2020 - 2023, USD Million
  • TABLE 134 Europe Others Market by Country, 2024 - 2031, USD Million
  • TABLE 135 Europe Human Insulin Market by Type of Insulin, 2020 - 2023, USD Million
  • TABLE 136 Europe Human Insulin Market by Type of Insulin, 2024 - 2031, USD Million
  • TABLE 137 Europe Rapid-acting insulin Market by Country, 2020 - 2023, USD Million
  • TABLE 138 Europe Rapid-acting insulin Market by Country, 2024 - 2031, USD Million
  • TABLE 139 Europe Short-acting insulin Market by Country, 2020 - 2023, USD Million
  • TABLE 140 Europe Short-acting insulin Market by Country, 2024 - 2031, USD Million
  • TABLE 141 Europe Intermediate-acting insulin Market by Country, 2020 - 2023, USD Million
  • TABLE 142 Europe Intermediate-acting insulin Market by Country, 2024 - 2031, USD Million
  • TABLE 143 Europe Others Market by Country, 2020 - 2023, USD Million
  • TABLE 144 Europe Others Market by Country, 2024 - 2031, USD Million
  • TABLE 145 Europe Human Insulin Market by Distribution Channel, 2020 - 2023, USD Million
  • TABLE 146 Europe Human Insulin Market by Distribution Channel, 2024 - 2031, USD Million
  • TABLE 147 Europe Hospital Pharmacies Market by Country, 2020 - 2023, USD Million
  • TABLE 148 Europe Hospital Pharmacies Market by Country, 2024 - 2031, USD Million
  • TABLE 149 Europe Drug Stores & Retail Pharmacies Market by Country, 2020 - 2023, USD Million
  • TABLE 150 Europe Drug Stores & Retail Pharmacies Market by Country, 2024 - 2031, USD Million
  • TABLE 151 Europe Online Providers Market by Country, 2020 - 2023, USD Million
  • TABLE 152 Europe Online Providers Market by Country, 2024 - 2031, USD Million
  • TABLE 153 Europe Human Insulin Market by Country, 2020 - 2023, USD Million
  • TABLE 154 Europe Human Insulin Market by Country, 2024 - 2031, USD Million
  • TABLE 155 Germany Human Insulin Market, 2020 - 2023, USD Million
  • TABLE 156 Germany Human Insulin Market, 2024 - 2031, USD Million
  • TABLE 157 Germany Human Insulin Market by Indication, 2020 - 2023, USD Million
  • TABLE 158 Germany Human Insulin Market by Indication, 2024 - 2031, USD Million
  • TABLE 159 Germany Human Insulin Market by Product Type, 2020 - 2023, USD Million
  • TABLE 160 Germany Human Insulin Market by Product Type, 2024 - 2031, USD Million
  • TABLE 161 Germany Human Insulin Market by Type of Insulin, 2020 - 2023, USD Million
  • TABLE 162 Germany Human Insulin Market by Type of Insulin, 2024 - 2031, USD Million
  • TABLE 163 Germany Human Insulin Market by Distribution Channel, 2020 - 2023, USD Million
  • TABLE 164 Germany Human Insulin Market by Distribution Channel, 2024 - 2031, USD Million
  • TABLE 165 UK Human Insulin Market, 2020 - 2023, USD Million
  • TABLE 166 UK Human Insulin Market, 2024 - 2031, USD Million
  • TABLE 167 UK Human Insulin Market by Indication, 2020 - 2023, USD Million
  • TABLE 168 UK Human Insulin Market by Indication, 2024 - 2031, USD Million
  • TABLE 169 UK Human Insulin Market by Product Type, 2020 - 2023, USD Million
  • TABLE 170 UK Human Insulin Market by Product Type, 2024 - 2031, USD Million
  • TABLE 171 UK Human Insulin Market by Type of Insulin, 2020 - 2023, USD Million
  • TABLE 172 UK Human Insulin Market by Type of Insulin, 2024 - 2031, USD Million
  • TABLE 173 UK Human Insulin Market by Distribution Channel, 2020 - 2023, USD Million
  • TABLE 174 UK Human Insulin Market by Distribution Channel, 2024 - 2031, USD Million
  • TABLE 175 France Human Insulin Market, 2020 - 2023, USD Million
  • TABLE 176 France Human Insulin Market, 2024 - 2031, USD Million
  • TABLE 177 France Human Insulin Market by Indication, 2020 - 2023, USD Million
  • TABLE 178 France Human Insulin Market by Indication, 2024 - 2031, USD Million
  • TABLE 179 France Human Insulin Market by Product Type, 2020 - 2023, USD Million
  • TABLE 180 France Human Insulin Market by Product Type, 2024 - 2031, USD Million
  • TABLE 181 France Human Insulin Market by Type of Insulin, 2020 - 2023, USD Million
  • TABLE 182 France Human Insulin Market by Type of Insulin, 2024 - 2031, USD Million
  • TABLE 183 France Human Insulin Market by Distribution Channel, 2020 - 2023, USD Million
  • TABLE 184 France Human Insulin Market by Distribution Channel, 2024 - 2031, USD Million
  • TABLE 185 Russia Human Insulin Market, 2020 - 2023, USD Million
  • TABLE 186 Russia Human Insulin Market, 2024 - 2031, USD Million
  • TABLE 187 Russia Human Insulin Market by Indication, 2020 - 2023, USD Million
  • TABLE 188 Russia Human Insulin Market by Indication, 2024 - 2031, USD Million
  • TABLE 189 Russia Human Insulin Market by Product Type, 2020 - 2023, USD Million
  • TABLE 190 Russia Human Insulin Market by Product Type, 2024 - 2031, USD Million
  • TABLE 191 Russia Human Insulin Market by Type of Insulin, 2020 - 2023, USD Million
  • TABLE 192 Russia Human Insulin Market by Type of Insulin, 2024 - 2031, USD Million
  • TABLE 193 Russia Human Insulin Market by Distribution Channel, 2020 - 2023, USD Million
  • TABLE 194 Russia Human Insulin Market by Distribution Channel, 2024 - 2031, USD Million
  • TABLE 195 Spain Human Insulin Market, 2020 - 2023, USD Million
  • TABLE 196 Spain Human Insulin Market, 2024 - 2031, USD Million
  • TABLE 197 Spain Human Insulin Market by Indication, 2020 - 2023, USD Million
  • TABLE 198 Spain Human Insulin Market by Indication, 2024 - 2031, USD Million
  • TABLE 199 Spain Human Insulin Market by Product Type, 2020 - 2023, USD Million
  • TABLE 200 Spain Human Insulin Market by Product Type, 2024 - 2031, USD Million
  • TABLE 201 Spain Human Insulin Market by Type of Insulin, 2020 - 2023, USD Million
  • TABLE 202 Spain Human Insulin Market by Type of Insulin, 2024 - 2031, USD Million
  • TABLE 203 Spain Human Insulin Market by Distribution Channel, 2020 - 2023, USD Million
  • TABLE 204 Spain Human Insulin Market by Distribution Channel, 2024 - 2031, USD Million
  • TABLE 205 Italy Human Insulin Market, 2020 - 2023, USD Million
  • TABLE 206 Italy Human Insulin Market, 2024 - 2031, USD Million
  • TABLE 207 Italy Human Insulin Market by Indication, 2020 - 2023, USD Million
  • TABLE 208 Italy Human Insulin Market by Indication, 2024 - 2031, USD Million
  • TABLE 209 Italy Human Insulin Market by Product Type, 2020 - 2023, USD Million
  • TABLE 210 Italy Human Insulin Market by Product Type, 2024 - 2031, USD Million
  • TABLE 211 Italy Human Insulin Market by Type of Insulin, 2020 - 2023, USD Million
  • TABLE 212 Italy Human Insulin Market by Type of Insulin, 2024 - 2031, USD Million
  • TABLE 213 Italy Human Insulin Market by Distribution Channel, 2020 - 2023, USD Million
  • TABLE 214 Italy Human Insulin Market by Distribution Channel, 2024 - 2031, USD Million
  • TABLE 215 Rest of Europe Human Insulin Market, 2020 - 2023, USD Million
  • TABLE 216 Rest of Europe Human Insulin Market, 2024 - 2031, USD Million
  • TABLE 217 Rest of Europe Human Insulin Market by Indication, 2020 - 2023, USD Million
  • TABLE 218 Rest of Europe Human Insulin Market by Indication, 2024 - 2031, USD Million
  • TABLE 219 Rest of Europe Human Insulin Market by Product Type, 2020 - 2023, USD Million
  • TABLE 220 Rest of Europe Human Insulin Market by Product Type, 2024 - 2031, USD Million
  • TABLE 221 Rest of Europe Human Insulin Market by Type of Insulin, 2020 - 2023, USD Million
  • TABLE 222 Rest of Europe Human Insulin Market by Type of Insulin, 2024 - 2031, USD Million
  • TABLE 223 Rest of Europe Human Insulin Market by Distribution Channel, 2020 - 2023, USD Million
  • TABLE 224 Rest of Europe Human Insulin Market by Distribution Channel, 2024 - 2031, USD Million
  • TABLE 225 Asia Pacific Human Insulin Market, 2020 - 2023, USD Million
  • TABLE 226 Asia Pacific Human Insulin Market, 2024 - 2031, USD Million
  • TABLE 227 Asia Pacific Human Insulin Market by Indication, 2020 - 2023, USD Million
  • TABLE 228 Asia Pacific Human Insulin Market by Indication, 2024 - 2031, USD Million
  • TABLE 229 Asia Pacific Type 1 Diabetes Market by Country, 2020 - 2023, USD Million
  • TABLE 230 Asia Pacific Type 1 Diabetes Market by Country, 2024 - 2031, USD Million
  • TABLE 231 Asia Pacific Type 2 Diabetes Market by Country, 2020 - 2023, USD Million
  • TABLE 232 Asia Pacific Type 2 Diabetes Market by Country, 2024 - 2031, USD Million
  • TABLE 233 Asia Pacific Gestational Diabetes Market by Country, 2020 - 2023, USD Million
  • TABLE 234 Asia Pacific Gestational Diabetes Market by Country, 2024 - 2031, USD Million
  • TABLE 235 Asia Pacific Human Insulin Market by Product Type, 2020 - 2023, USD Million
  • TABLE 236 Asia Pacific Human Insulin Market by Product Type, 2024 - 2031, USD Million
  • TABLE 237 Asia Pacific Pens Market by Country, 2020 - 2023, USD Million
  • TABLE 238 Asia Pacific Pens Market by Country, 2024 - 2031, USD Million
  • TABLE 239 Asia Pacific Syringes Market by Country, 2020 - 2023, USD Million
  • TABLE 240 Asia Pacific Syringes Market by Country, 2024 - 2031, USD Million
  • TABLE 241 Asia Pacific Others Market by Country, 2020 - 2023, USD Million
  • TABLE 242 Asia Pacific Others Market by Country, 2024 - 2031, USD Million
  • TABLE 243 Asia Pacific Human Insulin Market by Type of Insulin, 2020 - 2023, USD Million
  • TABLE 244 Asia Pacific Human Insulin Market by Type of Insulin, 2024 - 2031, USD Million
  • TABLE 245 Asia Pacific Rapid-acting insulin Market by Country, 2020 - 2023, USD Million
  • TABLE 246 Asia Pacific Rapid-acting insulin Market by Country, 2024 - 2031, USD Million
  • TABLE 247 Asia Pacific Short-acting insulin Market by Country, 2020 - 2023, USD Million
  • TABLE 248 Asia Pacific Short-acting insulin Market by Country, 2024 - 2031, USD Million
  • TABLE 249 Asia Pacific Intermediate-acting insulin Market by Country, 2020 - 2023, USD Million
  • TABLE 250 Asia Pacific Intermediate-acting insulin Market by Country, 2024 - 2031, USD Million
  • TABLE 251 Asia Pacific Others Market by Country, 2020 - 2023, USD Million
  • TABLE 252 Asia Pacific Others Market by Country, 2024 - 2031, USD Million
  • TABLE 253 Asia Pacific Human Insulin Market by Distribution Channel, 2020 - 2023, USD Million
  • TABLE 254 Asia Pacific Human Insulin Market by Distribution Channel, 2024 - 2031, USD Million
  • TABLE 255 Asia Pacific Hospital Pharmacies Market by Country, 2020 - 2023, USD Million
  • TABLE 256 Asia Pacific Hospital Pharmacies Market by Country, 2024 - 2031, USD Million
  • TABLE 257 Asia Pacific Drug Stores & Retail Pharmacies Market by Country, 2020 - 2023, USD Million
  • TABLE 258 Asia Pacific Drug Stores & Retail Pharmacies Market by Country, 2024 - 2031, USD Million
  • TABLE 259 Asia Pacific Online Providers Market by Country, 2020 - 2023, USD Million
  • TABLE 260 Asia Pacific Online Providers Market by Country, 2024 - 2031, USD Million
  • TABLE 261 Asia Pacific Human Insulin Market by Country, 2020 - 2023, USD Million
  • TABLE 262 Asia Pacific Human Insulin Market by Country, 2024 - 2031, USD Million
  • TABLE 263 China Human Insulin Market, 2020 - 2023, USD Million
  • TABLE 264 China Human Insulin Market, 2024 - 2031, USD Million
  • TABLE 265 China Human Insulin Market by Indication, 2020 - 2023, USD Million
  • TABLE 266 China Human Insulin Market by Indication, 2024 - 2031, USD Million
  • TABLE 267 China Human Insulin Market by Product Type, 2020 - 2023, USD Million
  • TABLE 268 China Human Insulin Market by Product Type, 2024 - 2031, USD Million
  • TABLE 269 China Human Insulin Market by Type of Insulin, 2020 - 2023, USD Million
  • TABLE 270 China Human Insulin Market by Type of Insulin, 2024 - 2031, USD Million
  • TABLE 271 China Human Insulin Market by Distribution Channel, 2020 - 2023, USD Million
  • TABLE 272 China Human Insulin Market by Distribution Channel, 2024 - 2031, USD Million
  • TABLE 273 Japan Human Insulin Market, 2020 - 2023, USD Million
  • TABLE 274 Japan Human Insulin Market, 2024 - 2031, USD Million
  • TABLE 275 Japan Human Insulin Market by Indication, 2020 - 2023, USD Million
  • TABLE 276 Japan Human Insulin Market by Indication, 2024 - 2031, USD Million
  • TABLE 277 Japan Human Insulin Market by Product Type, 2020 - 2023, USD Million
  • TABLE 278 Japan Human Insulin Market by Product Type, 2024 - 2031, USD Million
  • TABLE 279 Japan Human Insulin Market by Type of Insulin, 2020 - 2023, USD Million
  • TABLE 280 Japan Human Insulin Market by Type of Insulin, 2024 - 2031, USD Million
  • TABLE 281 Japan Human Insulin Market by Distribution Channel, 2020 - 2023, USD Million
  • TABLE 282 Japan Human Insulin Market by Distribution Channel, 2024 - 2031, USD Million
  • TABLE 283 India Human Insulin Market, 2020 - 2023, USD Million
  • TABLE 284 India Human Insulin Market, 2024 - 2031, USD Million
  • TABLE 285 India Human Insulin Market by Indication, 2020 - 2023, USD Million
  • TABLE 286 India Human Insulin Market by Indication, 2024 - 2031, USD Million
  • TABLE 287 India Human Insulin Market by Product Type, 2020 - 2023, USD Million
  • TABLE 288 India Human Insulin Market by Product Type, 2024 - 2031, USD Million
  • TABLE 289 India Human Insulin Market by Type of Insulin, 2020 - 2023, USD Million
  • TABLE 290 India Human Insulin Market by Type of Insulin, 2024 - 2031, USD Million
  • TABLE 291 India Human Insulin Market by Distribution Channel, 2020 - 2023, USD Million
  • TABLE 292 India Human Insulin Market by Distribution Channel, 2024 - 2031, USD Million
  • TABLE 293 South Korea Human Insulin Market, 2020 - 2023, USD Million
  • TABLE 294 South Korea Human Insulin Market, 2024 - 2031, USD Million
  • TABLE 295 South Korea Human Insulin Market by Indication, 2020 - 2023, USD Million
  • TABLE 296 South Korea Human Insulin Market by Indication, 2024 - 2031, USD Million
  • TABLE 297 South Korea Human Insulin Market by Product Type, 2020 - 2023, USD Million
  • TABLE 298 South Korea Human Insulin Market by Product Type, 2024 - 2031, USD Million
  • TABLE 299 South Korea Human Insulin Market by Type of Insulin, 2020 - 2023, USD Million
  • TABLE 300 South Korea Human Insulin Market by Type of Insulin, 2024 - 2031, USD Million
  • TABLE 301 South Korea Human Insulin Market by Distribution Channel, 2020 - 2023, USD Million
  • TABLE 302 South Korea Human Insulin Market by Distribution Channel, 2024 - 2031, USD Million
  • TABLE 303 Singapore Human Insulin Market, 2020 - 2023, USD Million
  • TABLE 304 Singapore Human Insulin Market, 2024 - 2031, USD Million
  • TABLE 305 Singapore Human Insulin Market by Indication, 2020 - 2023, USD Million
  • TABLE 306 Singapore Human Insulin Market by Indication, 2024 - 2031, USD Million
  • TABLE 307 Singapore Human Insulin Market by Product Type, 2020 - 2023, USD Million
  • TABLE 308 Singapore Human Insulin Market by Product Type, 2024 - 2031, USD Million
  • TABLE 309 Singapore Human Insulin Market by Type of Insulin, 2020 - 2023, USD Million
  • TABLE 310 Singapore Human Insulin Market by Type of Insulin, 2024 - 2031, USD Million
  • TABLE 311 Singapore Human Insulin Market by Distribution Channel, 2020 - 2023, USD Million
  • TABLE 312 Singapore Human Insulin Market by Distribution Channel, 2024 - 2031, USD Million
  • TABLE 313 Malaysia Human Insulin Market, 2020 - 2023, USD Million
  • TABLE 314 Malaysia Human Insulin Market, 2024 - 2031, USD Million
  • TABLE 315 Malaysia Human Insulin Market by Indication, 2020 - 2023, USD Million
  • TABLE 316 Malaysia Human Insulin Market by Indication, 2024 - 2031, USD Million
  • TABLE 317 Malaysia Human Insulin Market by Product Type, 2020 - 2023, USD Million
  • TABLE 318 Malaysia Human Insulin Market by Product Type, 2024 - 2031, USD Million
  • TABLE 319 Malaysia Human Insulin Market by Type of Insulin, 2020 - 2023, USD Million
  • TABLE 320 Malaysia Human Insulin Market by Type of Insulin, 2024 - 2031, USD Million
  • TABLE 321 Malaysia Human Insulin Market by Distribution Channel, 2020 - 2023, USD Million
  • TABLE 322 Malaysia Human Insulin Market by Distribution Channel, 2024 - 2031, USD Million
  • TABLE 323 Rest of Asia Pacific Human Insulin Market, 2020 - 2023, USD Million
  • TABLE 324 Rest of Asia Pacific Human Insulin Market, 2024 - 2031, USD Million
  • TABLE 325 Rest of Asia Pacific Human Insulin Market by Indication, 2020 - 2023, USD Million
  • TABLE 326 Rest of Asia Pacific Human Insulin Market by Indication, 2024 - 2031, USD Million
  • TABLE 327 Rest of Asia Pacific Human Insulin Market by Product Type, 2020 - 2023, USD Million
  • TABLE 328 Rest of Asia Pacific Human Insulin Market by Product Type, 2024 - 2031, USD Million
  • TABLE 329 Rest of Asia Pacific Human Insulin Market by Type of Insulin, 2020 - 2023, USD Million
  • TABLE 330 Rest of Asia Pacific Human Insulin Market by Type of Insulin, 2024 - 2031, USD Million
  • TABLE 331 Rest of Asia Pacific Human Insulin Market by Distribution Channel, 2020 - 2023, USD Million
  • TABLE 332 Rest of Asia Pacific Human Insulin Market by Distribution Channel, 2024 - 2031, USD Million
  • TABLE 333 LAMEA Human Insulin Market, 2020 - 2023, USD Million
  • TABLE 334 LAMEA Human Insulin Market, 2024 - 2031, USD Million
  • TABLE 335 LAMEA Human Insulin Market by Indication, 2020 - 2023, USD Million
  • TABLE 336 LAMEA Human Insulin Market by Indication, 2024 - 2031, USD Million
  • TABLE 337 LAMEA Type 1 Diabetes Market by Country, 2020 - 2023, USD Million
  • TABLE 338 LAMEA Type 1 Diabetes Market by Country, 2024 - 2031, USD Million
  • TABLE 339 LAMEA Type 2 Diabetes Market by Country, 2020 - 2023, USD Million
  • TABLE 340 LAMEA Type 2 Diabetes Market by Country, 2024 - 2031, USD Million
  • TABLE 341 LAMEA Gestational Diabetes Market by Country, 2020 - 2023, USD Million
  • TABLE 342 LAMEA Gestational Diabetes Market by Country, 2024 - 2031, USD Million
  • TABLE 343 LAMEA Human Insulin Market by Product Type, 2020 - 2023, USD Million
  • TABLE 344 LAMEA Human Insulin Market by Product Type, 2024 - 2031, USD Million
  • TABLE 345 LAMEA Pens Market by Country, 2020 - 2023, USD Million
  • TABLE 346 LAMEA Pens Market by Country, 2024 - 2031, USD Million
  • TABLE 347 LAMEA Syringes Market by Country, 2020 - 2023, USD Million
  • TABLE 348 LAMEA Syringes Market by Country, 2024 - 2031, USD Million
  • TABLE 349 LAMEA Others Market by Country, 2020 - 2023, USD Million
  • TABLE 350 LAMEA Others Market by Country, 2024 - 2031, USD Million
  • TABLE 351 LAMEA Human Insulin Market by Type of Insulin, 2020 - 2023, USD Million
  • TABLE 352 LAMEA Human Insulin Market by Type of Insulin, 2024 - 2031, USD Million
  • TABLE 353 LAMEA Rapid-acting insulin Market by Country, 2020 - 2023, USD Million
  • TABLE 354 LAMEA Rapid-acting insulin Market by Country, 2024 - 2031, USD Million
  • TABLE 355 LAMEA Short-acting insulin Market by Country, 2020 - 2023, USD Million
  • TABLE 356 LAMEA Short-acting insulin Market by Country, 2024 - 2031, USD Million
  • TABLE 357 LAMEA Intermediate-acting insulin Market by Country, 2020 - 2023, USD Million
  • TABLE 358 LAMEA Intermediate-acting insulin Market by Country, 2024 - 2031, USD Million
  • TABLE 359 LAMEA Others Market by Country, 2020 - 2023, USD Million
  • TABLE 360 LAMEA Others Market by Country, 2024 - 2031, USD Million
  • TABLE 361 LAMEA Human Insulin Market by Distribution Channel, 2020 - 2023, USD Million
  • TABLE 362 LAMEA Human Insulin Market by Distribution Channel, 2024 - 2031, USD Million
  • TABLE 363 LAMEA Hospital Pharmacies Market by Country, 2020 - 2023, USD Million
  • TABLE 364 LAMEA Hospital Pharmacies Market by Country, 2024 - 2031, USD Million
  • TABLE 365 LAMEA Drug Stores & Retail Pharmacies Market by Country, 2020 - 2023, USD Million
  • TABLE 366 LAMEA Drug Stores & Retail Pharmacies Market by Country, 2024 - 2031, USD Million
  • TABLE 367 LAMEA Online Providers Market by Country, 2020 - 2023, USD Million
  • TABLE 368 LAMEA Online Providers Market by Country, 2024 - 2031, USD Million
  • TABLE 369 LAMEA Human Insulin Market by Country, 2020 - 2023, USD Million
  • TABLE 370 LAMEA Human Insulin Market by Country, 2024 - 2031, USD Million
  • TABLE 371 Brazil Human Insulin Market, 2020 - 2023, USD Million
  • TABLE 372 Brazil Human Insulin Market, 2024 - 2031, USD Million
  • TABLE 373 Brazil Human Insulin Market by Indication, 2020 - 2023, USD Million
  • TABLE 374 Brazil Human Insulin Market by Indication, 2024 - 2031, USD Million
  • TABLE 375 Brazil Human Insulin Market by Product Type, 2020 - 2023, USD Million
  • TABLE 376 Brazil Human Insulin Market by Product Type, 2024 - 2031, USD Million
  • TABLE 377 Brazil Human Insulin Market by Type of Insulin, 2020 - 2023, USD Million
  • TABLE 378 Brazil Human Insulin Market by Type of Insulin, 2024 - 2031, USD Million
  • TABLE 379 Brazil Human Insulin Market by Distribution Channel, 2020 - 2023, USD Million
  • TABLE 380 Brazil Human Insulin Market by Distribution Channel, 2024 - 2031, USD Million
  • TABLE 381 Argentina Human Insulin Market, 2020 - 2023, USD Million
  • TABLE 382 Argentina Human Insulin Market, 2024 - 2031, USD Million
  • TABLE 383 Argentina Human Insulin Market by Indication, 2020 - 2023, USD Million
  • TABLE 384 Argentina Human Insulin Market by Indication, 2024 - 2031, USD Million
  • TABLE 385 Argentina Human Insulin Market by Product Type, 2020 - 2023, USD Million
  • TABLE 386 Argentina Human Insulin Market by Product Type, 2024 - 2031, USD Million
  • TABLE 387 Argentina Human Insulin Market by Type of Insulin, 2020 - 2023, USD Million
  • TABLE 388 Argentina Human Insulin Market by Type of Insulin, 2024 - 2031, USD Million
  • TABLE 389 Argentina Human Insulin Market by Distribution Channel, 2020 - 2023, USD Million
  • TABLE 390 Argentina Human Insulin Market by Distribution Channel, 2024 - 2031, USD Million
  • TABLE 391 UAE Human Insulin Market, 2020 - 2023, USD Million
  • TABLE 392 UAE Human Insulin Market, 2024 - 2031, USD Million
  • TABLE 393 UAE Human Insulin Market by Indication, 2020 - 2023, USD Million
  • TABLE 394 UAE Human Insulin Market by Indication, 2024 - 2031, USD Million
  • TABLE 395 UAE Human Insulin Market by Product Type, 2020 - 2023, USD Million
  • TABLE 396 UAE Human Insulin Market by Product Type, 2024 - 2031, USD Million
  • TABLE 397 UAE Human Insulin Market by Type of Insulin, 2020 - 2023, USD Million
  • TABLE 398 UAE Human Insulin Market by Type of Insulin, 2024 - 2031, USD Million
  • TABLE 399 UAE Human Insulin Market by Distribution Channel, 2020 - 2023, USD Million
  • TABLE 400 UAE Human Insulin Market by Distribution Channel, 2024 - 2031, USD Million
  • TABLE 401 Saudi Arabia Human Insulin Market, 2020 - 2023, USD Million
  • TABLE 402 Saudi Arabia Human Insulin Market, 2024 - 2031, USD Million
  • TABLE 403 Saudi Arabia Human Insulin Market by Indication, 2020 - 2023, USD Million
  • TABLE 404 Saudi Arabia Human Insulin Market by Indication, 2024 - 2031, USD Million
  • TABLE 405 Saudi Arabia Human Insulin Market by Product Type, 2020 - 2023, USD Million
  • TABLE 406 Saudi Arabia Human Insulin Market by Product Type, 2024 - 2031, USD Million
  • TABLE 407 Saudi Arabia Human Insulin Market by Type of Insulin, 2020 - 2023, USD Million
  • TABLE 408 Saudi Arabia Human Insulin Market by Type of Insulin, 2024 - 2031, USD Million
  • TABLE 409 Saudi Arabia Human Insulin Market by Distribution Channel, 2020 - 2023, USD Million
  • TABLE 410 Saudi Arabia Human Insulin Market by Distribution Channel, 2024 - 2031, USD Million
  • TABLE 411 South Africa Human Insulin Market, 2020 - 2023, USD Million
  • TABLE 412 South Africa Human Insulin Market, 2024 - 2031, USD Million
  • TABLE 413 South Africa Human Insulin Market by Indication, 2020 - 2023, USD Million
  • TABLE 414 South Africa Human Insulin Market by Indication, 2024 - 2031, USD Million
  • TABLE 415 South Africa Human Insulin Market by Product Type, 2020 - 2023, USD Million
  • TABLE 416 South Africa Human Insulin Market by Product Type, 2024 - 2031, USD Million
  • TABLE 417 South Africa Human Insulin Market by Type of Insulin, 2020 - 2023, USD Million
  • TABLE 418 South Africa Human Insulin Market by Type of Insulin, 2024 - 2031, USD Million
  • TABLE 419 South Africa Human Insulin Market by Distribution Channel, 2020 - 2023, USD Million
  • TABLE 420 South Africa Human Insulin Market by Distribution Channel, 2024 - 2031, USD Million
  • TABLE 421 Nigeria Human Insulin Market, 2020 - 2023, USD Million
  • TABLE 422 Nigeria Human Insulin Market, 2024 - 2031, USD Million
  • TABLE 423 Nigeria Human Insulin Market by Indication, 2020 - 2023, USD Million
  • TABLE 424 Nigeria Human Insulin Market by Indication, 2024 - 2031, USD Million
  • TABLE 425 Nigeria Human Insulin Market by Product Type, 2020 - 2023, USD Million
  • TABLE 426 Nigeria Human Insulin Market by Product Type, 2024 - 2031, USD Million
  • TABLE 427 Nigeria Human Insulin Market by Type of Insulin, 2020 - 2023, USD Million
  • TABLE 428 Nigeria Human Insulin Market by Type of Insulin, 2024 - 2031, USD Million
  • TABLE 429 Nigeria Human Insulin Market by Distribution Channel, 2020 - 2023, USD Million
  • TABLE 430 Nigeria Human Insulin Market by Distribution Channel, 2024 - 2031, USD Million
  • TABLE 431 Rest of LAMEA Human Insulin Market, 2020 - 2023, USD Million
  • TABLE 432 Rest of LAMEA Human Insulin Market, 2024 - 2031, USD Million
  • TABLE 433 Rest of LAMEA Human Insulin Market by Indication, 2020 - 2023, USD Million
  • TABLE 434 Rest of LAMEA Human Insulin Market by Indication, 2024 - 2031, USD Million
  • TABLE 435 Rest of LAMEA Human Insulin Market by Product Type, 2020 - 2023, USD Million
  • TABLE 436 Rest of LAMEA Human Insulin Market by Product Type, 2024 - 2031, USD Million
  • TABLE 437 Rest of LAMEA Human Insulin Market by Type of Insulin, 2020 - 2023, USD Million
  • TABLE 438 Rest of LAMEA Human Insulin Market by Type of Insulin, 2024 - 2031, USD Million
  • TABLE 439 Rest of LAMEA Human Insulin Market by Distribution Channel, 2020 - 2023, USD Million
  • TABLE 440 Rest of LAMEA Human Insulin Market by Distribution Channel, 2024 - 2031, USD Million
  • TABLE 441 Key Information - Biocon Limited
  • TABLE 442 Key Information - Tonghua Dongbao Pharmaceutical Co., Ltd.
  • TABLE 443 Key Information - Lupin Limited
  • TABLE 444 Key Information - MannKind Corporation
  • TABLE 445 Key Information - Sanofi S.A.
  • TABLE 446 Key Information - Novo Nordisk A/S
  • TABLE 447 Key Information - Medtronic PLC
  • TABLE 448 Key Information - Eli Lilly And Company
  • TABLE 449 Key Information - Pfizer, Inc.
目次

The Global Human Insulin Market size is expected to reach $20.5 billion by 2031, rising at a market growth of 3.2% CAGR during the forecast period.

Germany, France, and the United Kingdom are among the countries in Europe with a substantial diabetic population. These countries have comprehensive healthcare systems that offer extensive support for diabetes management. The availability of advanced insulin products, including analogs and innovative delivery systems, has driven the European market. Consequently, the European region would acquire nearly 31% of the total market share by 2031.

The expansion of the market is being driven by a number of significant causes, one of the most important of which is the worldwide increase in the population of diabetic patients. The development of type 2 diabetes has been facilitated by the environment created by modern lifestyles, which are characterized by a decrease in physical activity and an increase in the ingestion of unhealthy foods. Hence, the increasing prevalence of diabetes, driven by a combination of genetic, demographic, lifestyle, and environmental factors, is a primary driver of the market.

Additionally, Innovations such as insulin pens, pumps, and continuous glucose monitoring (CGM) systems have revolutionized diabetes management, enhancing patient compliance, convenience, and overall quality of life. Continuous glucose monitoring systems represent a leap forward in diabetes management technology. Thus, the continuous evolution of these technologies is a significant driver of growth in the market.

However, Insulin prices have escalated dramatically over the past several decades, far outpacing inflation and wage growth. Even in developed countries, the high cost of insulin presents a formidable challenge. Although health insurance may cover some of the cost, out-of-pocket expenses can still be prohibitively high. Hence, the high cost of insulin is hampering the market's growth.

Moreover, Economic repercussions of the pandemic strained the market. Many individuals faced financial hardships due to job losses and reduced income, which impacted their ability to afford medications, including insulin. With social distancing measures and restrictions on in-person visits, telemedicine became vital for managing diabetes remotely. Thus, the pandemic had an overall negative impact on the market.

Indication Outlook

On the basis of indication, the market is classified into type 1 diabetes, type 2 diabetes, and gestational diabetes. The type 2 diabetes segment recorded a 40% revenue share in the market in 2023. The prevalence of type 2 diabetes is higher than that of type 1 diabetes, and it is commonly associated with lifestyle variables such as being overweight, deficient in physical activity and having an unhealthy diet.

Product Type Outlook

Based on product type, the market is divided into pens, syringes, and others. The syringes segment procured 30% revenue share in the market in 2023. Affordability is a significant driver, making syringes a viable option for patients in low- and middle-income countries and those without extensive health insurance coverage.

Type of Insulin Outlook

By type of insulin, the market is divided into rapid-acting insulin, short-acting insulin, intermediate-acting insulin, and others. The short-acting insulin segment garnered 23% revenue share in the market in 2023. Short-acting insulins, such as regular insulin, have an onset of action within 30 minutes to an hour and peak in about two to four hours.

Distribution Channel Outlook

Based on distribution channel, the market is segmented into hospital pharmacies, drug stores & retail pharmacies, and online providers. The drug stores & retail pharmacies segment acquired 37% revenue share in the market in 2023. Drug stores and retail pharmacies are accessible and familiar to many patients, providing a convenient option for obtaining insulin and other diabetes-related supplies.

Regional Outlook

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America segment recorded 36% revenue share in the market in 2023. The region is home to a significant portion of the global diabetic population, with countries such as the US and Canada experiencing high and rising prevalence rates of diabetes.

List of Key Companies Profiled

  • MannKind Corporation
  • Lupin Limited
  • Sanofi S.A.
  • Novo Nordisk A/S
  • Eli Lilly And Company
  • Medtronic PLC
  • Biocon Limited
  • Tonghua Dongbao Pharmaceutical Co., Ltd.
  • Pfizer, Inc.

Global Human Insulin Market Report Segmentation

By Indication

  • Type 1 Diabetes
  • Type 2 Diabetes
  • Gestational Diabetes

By Product Type

  • Pens
  • Syringes
  • Others

By Type of Insulin

  • Rapid-acting insulin
  • Short-acting insulin
  • Intermediate-acting insulin
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Drug Stores & Retail Pharmacies
  • Online Providers

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Human Insulin Market, by Indication
    • 1.4.2 Global Human Insulin Market, by Product Type
    • 1.4.3 Global Human Insulin Market, by Type of Insulin
    • 1.4.4 Global Human Insulin Market, by Distribution Channel
    • 1.4.5 Global Human Insulin Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market at a Glance

  • 2.1 Key Highlights

Chapter 3. Market Overview

  • 3.1 Introduction
    • 3.1.1 Overview
      • 3.1.1.1 Market Composition and Scenario
  • 3.2 Key Factors Impacting the Market
    • 3.2.1 Market Drivers
    • 3.2.2 Market Restraints
    • 3.2.3 Market Opportunities
    • 3.2.4 Market Challenges
  • 3.3 Porter Five Forces Analysis

Chapter 4. Global Human Insulin Market by Indication

  • 4.1 Global Type 1 Diabetes Market by Region
  • 4.2 Global Type 2 Diabetes Market by Region
  • 4.3 Global Gestational Diabetes Market by Region

Chapter 5. Global Human Insulin Market by Product Type

  • 5.1 Global Pens Market by Region
  • 5.2 Global Syringes Market by Region
  • 5.3 Global Others Market by Region

Chapter 6. Global Human Insulin Market by Type of Insulin

  • 6.1 Global Rapid-acting insulin Market by Region
  • 6.2 Global Short-acting insulin Market by Region
  • 6.3 Global Intermediate-acting insulin Market by Region
  • 6.4 Global Others Market by Region

Chapter 7. Global Human Insulin Market by Distribution Channel

  • 7.1 Global Hospital Pharmacies Market by Region
  • 7.2 Global Drug Stores & Retail Pharmacies Market by Region
  • 7.3 Global Online Providers Market by Region

Chapter 8. Global Human Insulin Market by Region

  • 8.1 North America Human Insulin Market
    • 8.1.1 North America Human Insulin Market by Indication
      • 8.1.1.1 North America Type 1 Diabetes Market by Country
      • 8.1.1.2 North America Type 2 Diabetes Market by Country
      • 8.1.1.3 North America Gestational Diabetes Market by Country
    • 8.1.2 North America Human Insulin Market by Product Type
      • 8.1.2.1 North America Pens Market by Country
      • 8.1.2.2 North America Syringes Market by Country
      • 8.1.2.3 North America Others Market by Country
    • 8.1.3 North America Human Insulin Market by Type of Insulin
      • 8.1.3.1 North America Rapid-acting insulin Market by Country
      • 8.1.3.2 North America Short-acting insulin Market by Country
      • 8.1.3.3 North America Intermediate-acting insulin Market by Country
      • 8.1.3.4 North America Others Market by Country
    • 8.1.4 North America Human Insulin Market by Distribution Channel
      • 8.1.4.1 North America Hospital Pharmacies Market by Country
      • 8.1.4.2 North America Drug Stores & Retail Pharmacies Market by Country
      • 8.1.4.3 North America Online Providers Market by Country
    • 8.1.5 North America Human Insulin Market by Country
      • 8.1.5.1 US Human Insulin Market
        • 8.1.5.1.1 US Human Insulin Market by Indication
        • 8.1.5.1.2 US Human Insulin Market by Product Type
        • 8.1.5.1.3 US Human Insulin Market by Type of Insulin
        • 8.1.5.1.4 US Human Insulin Market by Distribution Channel
      • 8.1.5.2 Canada Human Insulin Market
        • 8.1.5.2.1 Canada Human Insulin Market by Indication
        • 8.1.5.2.2 Canada Human Insulin Market by Product Type
        • 8.1.5.2.3 Canada Human Insulin Market by Type of Insulin
        • 8.1.5.2.4 Canada Human Insulin Market by Distribution Channel
      • 8.1.5.3 Mexico Human Insulin Market
        • 8.1.5.3.1 Mexico Human Insulin Market by Indication
        • 8.1.5.3.2 Mexico Human Insulin Market by Product Type
        • 8.1.5.3.3 Mexico Human Insulin Market by Type of Insulin
        • 8.1.5.3.4 Mexico Human Insulin Market by Distribution Channel
      • 8.1.5.4 Rest of North America Human Insulin Market
        • 8.1.5.4.1 Rest of North America Human Insulin Market by Indication
        • 8.1.5.4.2 Rest of North America Human Insulin Market by Product Type
        • 8.1.5.4.3 Rest of North America Human Insulin Market by Type of Insulin
        • 8.1.5.4.4 Rest of North America Human Insulin Market by Distribution Channel
  • 8.2 Europe Human Insulin Market
    • 8.2.1 Europe Human Insulin Market by Indication
      • 8.2.1.1 Europe Type 1 Diabetes Market by Country
      • 8.2.1.2 Europe Type 2 Diabetes Market by Country
      • 8.2.1.3 Europe Gestational Diabetes Market by Country
    • 8.2.2 Europe Human Insulin Market by Product Type
      • 8.2.2.1 Europe Pens Market by Country
      • 8.2.2.2 Europe Syringes Market by Country
      • 8.2.2.3 Europe Others Market by Country
    • 8.2.3 Europe Human Insulin Market by Type of Insulin
      • 8.2.3.1 Europe Rapid-acting insulin Market by Country
      • 8.2.3.2 Europe Short-acting insulin Market by Country
      • 8.2.3.3 Europe Intermediate-acting insulin Market by Country
      • 8.2.3.4 Europe Others Market by Country
    • 8.2.4 Europe Human Insulin Market by Distribution Channel
      • 8.2.4.1 Europe Hospital Pharmacies Market by Country
      • 8.2.4.2 Europe Drug Stores & Retail Pharmacies Market by Country
      • 8.2.4.3 Europe Online Providers Market by Country
    • 8.2.5 Europe Human Insulin Market by Country
      • 8.2.5.1 Germany Human Insulin Market
        • 8.2.5.1.1 Germany Human Insulin Market by Indication
        • 8.2.5.1.2 Germany Human Insulin Market by Product Type
        • 8.2.5.1.3 Germany Human Insulin Market by Type of Insulin
        • 8.2.5.1.4 Germany Human Insulin Market by Distribution Channel
      • 8.2.5.2 UK Human Insulin Market
        • 8.2.5.2.1 UK Human Insulin Market by Indication
        • 8.2.5.2.2 UK Human Insulin Market by Product Type
        • 8.2.5.2.3 UK Human Insulin Market by Type of Insulin
        • 8.2.5.2.4 UK Human Insulin Market by Distribution Channel
      • 8.2.5.3 France Human Insulin Market
        • 8.2.5.3.1 France Human Insulin Market by Indication
        • 8.2.5.3.2 France Human Insulin Market by Product Type
        • 8.2.5.3.3 France Human Insulin Market by Type of Insulin
        • 8.2.5.3.4 France Human Insulin Market by Distribution Channel
      • 8.2.5.4 Russia Human Insulin Market
        • 8.2.5.4.1 Russia Human Insulin Market by Indication
        • 8.2.5.4.2 Russia Human Insulin Market by Product Type
        • 8.2.5.4.3 Russia Human Insulin Market by Type of Insulin
        • 8.2.5.4.4 Russia Human Insulin Market by Distribution Channel
      • 8.2.5.5 Spain Human Insulin Market
        • 8.2.5.5.1 Spain Human Insulin Market by Indication
        • 8.2.5.5.2 Spain Human Insulin Market by Product Type
        • 8.2.5.5.3 Spain Human Insulin Market by Type of Insulin
        • 8.2.5.5.4 Spain Human Insulin Market by Distribution Channel
      • 8.2.5.6 Italy Human Insulin Market
        • 8.2.5.6.1 Italy Human Insulin Market by Indication
        • 8.2.5.6.2 Italy Human Insulin Market by Product Type
        • 8.2.5.6.3 Italy Human Insulin Market by Type of Insulin
        • 8.2.5.6.4 Italy Human Insulin Market by Distribution Channel
      • 8.2.5.7 Rest of Europe Human Insulin Market
        • 8.2.5.7.1 Rest of Europe Human Insulin Market by Indication
        • 8.2.5.7.2 Rest of Europe Human Insulin Market by Product Type
        • 8.2.5.7.3 Rest of Europe Human Insulin Market by Type of Insulin
        • 8.2.5.7.4 Rest of Europe Human Insulin Market by Distribution Channel
  • 8.3 Asia Pacific Human Insulin Market
    • 8.3.1 Asia Pacific Human Insulin Market by Indication
      • 8.3.1.1 Asia Pacific Type 1 Diabetes Market by Country
      • 8.3.1.2 Asia Pacific Type 2 Diabetes Market by Country
      • 8.3.1.3 Asia Pacific Gestational Diabetes Market by Country
    • 8.3.2 Asia Pacific Human Insulin Market by Product Type
      • 8.3.2.1 Asia Pacific Pens Market by Country
      • 8.3.2.2 Asia Pacific Syringes Market by Country
      • 8.3.2.3 Asia Pacific Others Market by Country
    • 8.3.3 Asia Pacific Human Insulin Market by Type of Insulin
      • 8.3.3.1 Asia Pacific Rapid-acting insulin Market by Country
      • 8.3.3.2 Asia Pacific Short-acting insulin Market by Country
      • 8.3.3.3 Asia Pacific Intermediate-acting insulin Market by Country
      • 8.3.3.4 Asia Pacific Others Market by Country
    • 8.3.4 Asia Pacific Human Insulin Market by Distribution Channel
      • 8.3.4.1 Asia Pacific Hospital Pharmacies Market by Country
      • 8.3.4.2 Asia Pacific Drug Stores & Retail Pharmacies Market by Country
      • 8.3.4.3 Asia Pacific Online Providers Market by Country
    • 8.3.5 Asia Pacific Human Insulin Market by Country
      • 8.3.5.1 China Human Insulin Market
        • 8.3.5.1.1 China Human Insulin Market by Indication
        • 8.3.5.1.2 China Human Insulin Market by Product Type
        • 8.3.5.1.3 China Human Insulin Market by Type of Insulin
        • 8.3.5.1.4 China Human Insulin Market by Distribution Channel
      • 8.3.5.2 Japan Human Insulin Market
        • 8.3.5.2.1 Japan Human Insulin Market by Indication
        • 8.3.5.2.2 Japan Human Insulin Market by Product Type
        • 8.3.5.2.3 Japan Human Insulin Market by Type of Insulin
        • 8.3.5.2.4 Japan Human Insulin Market by Distribution Channel
      • 8.3.5.3 India Human Insulin Market
        • 8.3.5.3.1 India Human Insulin Market by Indication
        • 8.3.5.3.2 India Human Insulin Market by Product Type
        • 8.3.5.3.3 India Human Insulin Market by Type of Insulin
        • 8.3.5.3.4 India Human Insulin Market by Distribution Channel
      • 8.3.5.4 South Korea Human Insulin Market
        • 8.3.5.4.1 South Korea Human Insulin Market by Indication
        • 8.3.5.4.2 South Korea Human Insulin Market by Product Type
        • 8.3.5.4.3 South Korea Human Insulin Market by Type of Insulin
        • 8.3.5.4.4 South Korea Human Insulin Market by Distribution Channel
      • 8.3.5.5 Singapore Human Insulin Market
        • 8.3.5.5.1 Singapore Human Insulin Market by Indication
        • 8.3.5.5.2 Singapore Human Insulin Market by Product Type
        • 8.3.5.5.3 Singapore Human Insulin Market by Type of Insulin
        • 8.3.5.5.4 Singapore Human Insulin Market by Distribution Channel
      • 8.3.5.6 Malaysia Human Insulin Market
        • 8.3.5.6.1 Malaysia Human Insulin Market by Indication
        • 8.3.5.6.2 Malaysia Human Insulin Market by Product Type
        • 8.3.5.6.3 Malaysia Human Insulin Market by Type of Insulin
        • 8.3.5.6.4 Malaysia Human Insulin Market by Distribution Channel
      • 8.3.5.7 Rest of Asia Pacific Human Insulin Market
        • 8.3.5.7.1 Rest of Asia Pacific Human Insulin Market by Indication
        • 8.3.5.7.2 Rest of Asia Pacific Human Insulin Market by Product Type
        • 8.3.5.7.3 Rest of Asia Pacific Human Insulin Market by Type of Insulin
        • 8.3.5.7.4 Rest of Asia Pacific Human Insulin Market by Distribution Channel
  • 8.4 LAMEA Human Insulin Market
    • 8.4.1 LAMEA Human Insulin Market by Indication
      • 8.4.1.1 LAMEA Type 1 Diabetes Market by Country
      • 8.4.1.2 LAMEA Type 2 Diabetes Market by Country
      • 8.4.1.3 LAMEA Gestational Diabetes Market by Country
    • 8.4.2 LAMEA Human Insulin Market by Product Type
      • 8.4.2.1 LAMEA Pens Market by Country
      • 8.4.2.2 LAMEA Syringes Market by Country
      • 8.4.2.3 LAMEA Others Market by Country
    • 8.4.3 LAMEA Human Insulin Market by Type of Insulin
      • 8.4.3.1 LAMEA Rapid-acting insulin Market by Country
      • 8.4.3.2 LAMEA Short-acting insulin Market by Country
      • 8.4.3.3 LAMEA Intermediate-acting insulin Market by Country
      • 8.4.3.4 LAMEA Others Market by Country
    • 8.4.4 LAMEA Human Insulin Market by Distribution Channel
      • 8.4.4.1 LAMEA Hospital Pharmacies Market by Country
      • 8.4.4.2 LAMEA Drug Stores & Retail Pharmacies Market by Country
      • 8.4.4.3 LAMEA Online Providers Market by Country
    • 8.4.5 LAMEA Human Insulin Market by Country
      • 8.4.5.1 Brazil Human Insulin Market
        • 8.4.5.1.1 Brazil Human Insulin Market by Indication
        • 8.4.5.1.2 Brazil Human Insulin Market by Product Type
        • 8.4.5.1.3 Brazil Human Insulin Market by Type of Insulin
        • 8.4.5.1.4 Brazil Human Insulin Market by Distribution Channel
      • 8.4.5.2 Argentina Human Insulin Market
        • 8.4.5.2.1 Argentina Human Insulin Market by Indication
        • 8.4.5.2.2 Argentina Human Insulin Market by Product Type
        • 8.4.5.2.3 Argentina Human Insulin Market by Type of Insulin
        • 8.4.5.2.4 Argentina Human Insulin Market by Distribution Channel
      • 8.4.5.3 UAE Human Insulin Market
        • 8.4.5.3.1 UAE Human Insulin Market by Indication
        • 8.4.5.3.2 UAE Human Insulin Market by Product Type
        • 8.4.5.3.3 UAE Human Insulin Market by Type of Insulin
        • 8.4.5.3.4 UAE Human Insulin Market by Distribution Channel
      • 8.4.5.4 Saudi Arabia Human Insulin Market
        • 8.4.5.4.1 Saudi Arabia Human Insulin Market by Indication
        • 8.4.5.4.2 Saudi Arabia Human Insulin Market by Product Type
        • 8.4.5.4.3 Saudi Arabia Human Insulin Market by Type of Insulin
        • 8.4.5.4.4 Saudi Arabia Human Insulin Market by Distribution Channel
      • 8.4.5.5 South Africa Human Insulin Market
        • 8.4.5.5.1 South Africa Human Insulin Market by Indication
        • 8.4.5.5.2 South Africa Human Insulin Market by Product Type
        • 8.4.5.5.3 South Africa Human Insulin Market by Type of Insulin
        • 8.4.5.5.4 South Africa Human Insulin Market by Distribution Channel
      • 8.4.5.6 Nigeria Human Insulin Market
        • 8.4.5.6.1 Nigeria Human Insulin Market by Indication
        • 8.4.5.6.2 Nigeria Human Insulin Market by Product Type
        • 8.4.5.6.3 Nigeria Human Insulin Market by Type of Insulin
        • 8.4.5.6.4 Nigeria Human Insulin Market by Distribution Channel
      • 8.4.5.7 Rest of LAMEA Human Insulin Market
        • 8.4.5.7.1 Rest of LAMEA Human Insulin Market by Indication
        • 8.4.5.7.2 Rest of LAMEA Human Insulin Market by Product Type
        • 8.4.5.7.3 Rest of LAMEA Human Insulin Market by Type of Insulin
        • 8.4.5.7.4 Rest of LAMEA Human Insulin Market by Distribution Channel

Chapter 9. Company Profiles

  • 9.1 Biocon Limited
    • 9.1.1 Company Overview
    • 9.1.2 Financial Analysis
    • 9.1.3 Research & Development Expenses
  • 9.2 Tonghua Dongbao Pharmaceutical Co., Ltd.
    • 9.2.1 Company Overview
  • 9.3 Lupin Limited
    • 9.3.1 Company Overview
    • 9.3.2 Financial Analysis
    • 9.3.3 Regional Analysis
    • 9.3.4 Research & Development Expenses
    • 9.3.5 SWOT Analysis
  • 9.4 MannKind Corporation
    • 9.4.1 Company Overview
    • 9.4.2 Financial Analysis
  • 9.5 Sanofi S.A.
    • 9.5.1 Company Overview
    • 9.5.2 Financial Analysis
    • 9.5.3 Segmental and Regional Analysis
    • 9.5.4 Research & Development Expense
    • 9.5.5 SWOT Analysis
  • 9.6 Novo Nordisk A/S
    • 9.6.1 Company Overview
    • 9.6.2 Financial Analysis
    • 9.6.3 Segmental & Regional Analysis
    • 9.6.4 Research & Development Expenses
    • 9.6.5 SWOT Analysis
  • 9.7 Medtronic PLC
    • 9.7.1 Company overview
    • 9.7.2 Financial Analysis
    • 9.7.3 Segmental and Regional Analysis
    • 9.7.4 Research & Development Expenses
    • 9.7.5 SWOT Analysis
  • 9.8 Eli Lilly And Company
    • 9.8.1 Company Overview
    • 9.8.2 Financial Analysis
    • 9.8.3 Regional Analysis
    • 9.8.4 Research & Development Expenses
    • 9.8.5 SWOT Analysis
  • 9.9 Pfizer, Inc.
    • 9.9.1 Company Overview
    • 9.9.2 Financial Analysis
    • 9.9.3 Regional & Segmental Analysis
    • 9.9.4 Research & Development Expense
    • 9.9.5 SWOT Analysis

Chapter 10. Winning Imperatives for Human Insulin Market